Cardiothoracic Surgery Unit, The Alfred Hospital, Melbourne, Vic., Australia.
Clin Transplant. 2012 Jan-Feb;26(1):E71-7. doi: 10.1111/j.1399-0012.2011.01562.x. Epub 2011 Dec 11.
The use of and indications for extracorporeal membrane oxygenation (ECMO) are expanding as its reliability improves with widely varying results reported. A retrospective review of 24 lung transplant recipients who required ECMO support postoperatively was performed with 13 patients requiring ECMO within the first 48 h ("early" group) and 11 requiring ECMO after seven d postoperatively ("late" group). The majority of early ECMO group had primary graft failure patients and the late ECMO group comprised patients with infection or non-specific graft failure. There were significant differences in outcomes between groups, with 10/13 in the early group and 4/11 in the late group successfully weaned from ECMO (p = 0.045). Six of the 13 patients in the early group and none of the late group survived to hospital discharge (p = 0.009). The late ECMO group had a much higher incidence of death owing to complications existing prior to institution of ECMO (essentially uncontrolled infection or organ failure). There were no differences in complications arising during ECMO between groups. Late institution of ECMO in lung transplant recipients for causes other than primary graft failure is associated with such poor survival that its use should be considered only in very select cases.
体外膜肺氧合(ECMO)的使用和适应证正在扩大,随着其可靠性的提高,报告的结果差异很大。对 24 例肺移植术后需要 ECMO 支持的患者进行回顾性分析,其中 13 例在术后 48 小时内需要 ECMO(“早期”组),11 例在术后 7 天需要 ECMO(“晚期”组)。早期 ECMO 组的大多数患者是原发性移植物衰竭,晚期 ECMO 组的患者是感染或非特异性移植物衰竭。两组患者的结局有显著差异,早期组 13 例中有 10 例成功撤机 ECMO,晚期组 11 例中有 4 例(p = 0.045)。早期组 13 例患者中有 6 例,晚期组无一例患者存活至出院(p = 0.009)。晚期 ECMO 组由于 ECMO 前存在的并发症(基本上是无法控制的感染或器官衰竭)而导致死亡率较高。两组患者在 ECMO 期间发生的并发症没有差异。对于原发性移植物衰竭以外的原因,晚期在肺移植患者中使用 ECMO 与如此差的生存率相关,因此应仅在非常特定的情况下考虑使用。